$3+ Billion Worldwide Pediatric Interventional Cardiology Industry to 2027 – Featuring Boston Scientific, Cardinal Health, Edwards Lifesciences and General Electric Among Others – Yahoo Finance

Share Article

DUBLIN, Oct. 4, 2022 /PRNewswire/ — The “Pediatric Interventional Cardiology Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” report has been added to  ResearchAndMarkets.com’s offering.
The global pediatric interventional cardiology market reached a value of US$ 2.28 billion in 2021. Looking forward, the market is projected to reach a value of US$ 3.46 billion by 2027, exhibiting a CAGR of 6.80% during 2022-2027.
Keeping in mind the uncertainties of COVID-19, the analyst is continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Pediatric interventional cardiology is a subset of cardiology that involves the use of specific catheter-based techniques to treat heart disorders in infants, children, and adolescents up to 18 years of age. They include balloon angioplasty, coil occlusion, stent implantation, and aortic valve stenosis.
As compared to conventional cardiological treatments, pediatric interventional cardiology is more minimally invasive, thus reducing post-surgery complications. Consequently, they are extensively employed for performing angioplasty, valvuloplasty, coronary thrombectomy, and congenital heart defect correction procedures across clinical testing laboratories, hospitals, cardiac centers, and research institutes.

The increasing instances of various congenital cardiac diseases in children, such as atrial septal defect (ASD), atrioventricular canal defect, patent ductus arteriosus (PDA), and ventricular septal defect (VSD) represent one of the key factors driving the pediatric interventional cardiology market growth. The introduction of novel and more efficient pediatric interventional cardiology devices, including catheters, bio-absorbable stents, guidewires, balloons, stents, vascular closure devices, atherectomy devices is acting as another major growth-inducing factor.
In line with this, the shifting inclination of patients toward non-invasive medical treatment procedures, along with the rising awareness regarding the associated benefits, such as lower risk of infection, shorter postoperative recovery times, and avoidance of large scars is also driving the market growth.
Other factors, including rising healthcare expenditure and the numerous initiatives being undertaken by governments of various nations to speed-up regulatory procedures, are creating a positive outlook for the market. The market is also driven by extensive research and development (R&D) activities, increasing consumer healthcare expenditure and investments by governments and non-government organizations (NGOs) for strengthening the existing healthcare infrastructure, and significant technological advancements in the field of cardiology.
Competitive Landscape
The competitive landscape of the industry has also been examined along with the profiles of the key players being Biotronik SE & Co. KG, Boston Scientific Corporation, Cardinal Health Inc., Edwards Lifesciences Corporation, General Electric Company, Koninklijke Philips N.V., Lepu Medical Technology (Beijing) Co. Ltd., Medtronic plc, NuMED Inc., Siemens Healthineers AG, Terumo Corporation and W. L. Gore & Associates Inc.

Key Questions Answered in This Report
How has the global pediatric interventional cardiology market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global pediatric interventional cardiology market?
What are the key regional markets?
What is the breakup of the market based on the device type?
What is the breakup of the market based on the procedure?
What is the breakup of the market based on the End-use?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global pediatric interventional cardiology market and who are the key players?
What is the degree of competition in the industry?
Key Topics Covered:

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

5 Global Pediatric Interventional Cardiology Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Device Type
6.1 Closure Devices
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Transcatheter Heart Valves
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Atherectomy Devices
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Catheters
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Balloons
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Stents
6.6.1 Market Trends
6.6.2 Market Forecast
6.7 Others
6.7.1 Market Trends
6.7.2 Market Forecast

7 Market Breakup by Procedure
7.1 Catheter-Based Valve Implantation
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Congenital Heart Defect Correction
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Angioplasty
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Coronary Thrombectomy
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast

8 Market Breakup by End Use
8.1 Clinical Testing Laboratories
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Hospitals
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Cardiac Centers
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Pediatric Clinics
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Research Institutions
8.5.1 Market Trends
8.5.2 Market Forecast

9 Market Breakup by Region

10 SWOT Analysis

11 Value Chain Analysis

12 Porters Five Forces Analysis

13 Price Analysis

14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Biotronik SE & Co. KG Company Overview Product Portfolio SWOT Analysis
14.3.2 Boston Scientific Corporation Company Overview Product Portfolio Financials SWOT Analysis
14.3.3 Cardinal Health Inc. Company Overview Product Portfolio Financials SWOT Analysis
14.3.4 Edwards Lifesciences Corporation Company Overview Product Portfolio Financials SWOT Analysis
14.3.5 General Electric Company Company Overview Product Portfolio Financials SWOT Analysis
14.3.6 Koninklijke Philips N.V. Company Overview Product Portfolio Financials SWOT Analysis
14.3.7 Lepu Medical Technology (Beijing) Co. Ltd. Company Overview Product Portfolio Financials
14.3.8 Medtronic plc Company Overview Product Portfolio Financials SWOT Analysis
14.3.9 NuMED Inc. Company Overview Product Portfolio
14.3.10 Siemens Healthineers AG Company Overview Product Portfolio Financials SWOT Analysis
14.3.11 Terumo Corporation Company Overview Product Portfolio Financials SWOT Analysis
14.3.12 W. L. Gore & Associates Inc. Company Overview Product Portfolio SWOT Analysis
For more information about this report visit https://www.researchandmarkets.com/r/cboik2
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/3-billion-worldwide-pediatric-interventional-cardiology-industry-to-2027—featuring-boston-scientific-cardinal-health-edwards-lifesciences-and-general-electric-among-others-301640724.html
SOURCE Research and Markets
The volatile market has investors playing it safe.
OPEC+ will cut oil production by 2 million barrels per day amid looming demand concerns and the ongoing friction between the West and Russia over the war in Ukraine.
Shares of electric vehicle (EV) stocks Nio (NYSE: NIO), Lucid Group (NASDAQ: LCID), and Lordstown Motors (NASDAQ: RIDE) fell on Wednesday, down 5.1%, 3.6%, and 4.9%, respectively, as of 2:17 p.m. EDT. After a huge amount of selling in September, stocks were beaten down, but the first two days in October saw some potentially good news on inflation. With traders trying to sniff out the first signs of inflation breaking, that was a good sign.
Beleaguered bank Credit Suisse is looking to sell its famed Savoy Hotel, located on Paradeplatz in the centre of Zurich's financial district, it said on Thursday. The Swiss bank regularly reviews its property portfolio as part of its global real-estate strategy, a spokesperson said. "As part of this process, the bank has decided to start a sales process for the Hotel Savoy," she said.
(Bloomberg) — The OPEC+ alliance agreed to its biggest production cut since the start of the pandemic in Vienna on Wednesday, a move that drew a swift rebuke from the US and prompted Goldman Sachs Group Inc. to increase its price forecast for global benchmark Brent crude this quarter.Here’s what leading analysts have to say about the oil market after the group pledged to slash daily output by 2 million barrels from November:Morgan Stanley“Brent will find its way to $100 a barrel quicker than we
Yahoo Finance Live looks at AMD's stock amid cuts to full-year revenue estimates from Wells Fargo.
Here's why stocks have come out of the gate with gusto to kick off the fourth quarter.
In this article, we will take a look at the 10 stocks recently upgraded by analysts. If you want to see some more stocks on the list, go directly to Analysts are Upgrading These 5 Stocks. U.S. stocks turned red on Wednesday morning after staying in positive territory during the last two trading sessions. Meanwhile, […]
The Dow Jones rallied strongly. Twitter stock soared as Tesla CEO Elon Musk gets set to bite a takeover bullet. Some Cathie Wood buys surged.
Outspoken Barstool Sports founder Dave Portnoy thinks that investors might miss opportunities to invest in the stock market if they are dominated by fear.
Create the bull call spread trade by first buying a call and then selling a further out-of-the-money call.
These two stocks are among the riskiest in the Berkshire Hathaway portfolio, but they could be huge winners.
Exxon Mobil (XOM) stock surged Wednesday after it signaled natural gas prices would support already strong third-quarter expectations. Despite steep growth estimates, the energy giant projects it will not match its record profits from Q2 as oil prices have retreated along with refining and chemical segment profits. Exxon reported its operating profit could come in at around $11 billion in…
Jeffrey Bierman, chief market technician at TheoTrade, has made prescient market calls this year. He sees year-end gains ahead, and sees two ridiculously cheap sectors to buy.
Two of the most prominent mortgage real estate investment trusts (REITs), Annaly Capital Management (NYSE: NLY) and AGNC Investment (NASDAQ: AGNC), were down sharply during trading on Wednesday. Annaly Capital was down as much as 9% on the day at around noon ET, while AGNC fell as far as 9.7% on the day at around the same time. As both Annaly Capital and AGNC Investment are mortgage REITs, they were each negatively affected by the latest news from the housing industry.
The banking giant may not collapse after all. Take advantage?
Investors got a little fear back on Wednesday, although the major market indexes ended the day well off their lows. Bond yields also moved higher, reversing course and reminding investors that the bear market hasn't proven itself to be over just yet. Energy stocks got a boost on Wednesday as oil prices moved higher by about $1.50 per barrel to finish above the $88 mark.
Lumen Technologies shares tumbled Wednesday after an analyst at Wells Fargo cited concerns over risks to the telecommunication company’s dividend. Wells Fargo analyst Eric Luebchow downgraded shares of Lumen (ticker: LUMN) to Equal Weight from Overweight and cut his12-month price target to $8 from $12.50. Shares of Lumen fell 10% Wednesday to $7.22 and were on track for their lowest close since September 1991.
Yahoo Finance Live checks out online retailer Chewy's stock following a boost to sales estimates.
Shares of the digital bank SoFi (NASDAQ: SOFI) traded roughly 5% lower as of 11:53 a.m. ET today. Meanwhile, shares of the buy now, pay later company Affirm (NASDAQ: AFRM) and the artificial-intelligence lender Upstart (NASDAQ: UPST) both traded about 6% down. Yesterday, stocks rallied after the Reserve Bank of Australia raised its benchmark interest rate by only 25 basis points instead of the 50-point hike that was expected.


You might also like

Surviving 2nd wave of corona

Surviving The 2nd Wave of Corona

‘This too shall pass away’ this famous Persian adage seems to be defeating us again and again in the case of COVID-19. Despite every effort